Accendra Health Inc’s filing revealed that its 10% Owner Coliseum Capital Management, L acquired Company’s shares for reported $3.71 million on Aug 12 ’25. In the deal valued at $5.15 per share,720,000 shares were bought. As a result of this transaction, Coliseum Capital Management, L now holds 12,282,955 shares worth roughly $28.5 million.
Then, Coliseum Capital Management, L bought 492,852 shares, generating $2,617,044 in total proceeds. Upon buying the shares at $5.31, the 10% Owner now owns 13,100,807 shares.
Before that, Coliseum Capital Management, L bought 325,000 shares. Accendra Health Inc shares valued at $1,774,500 were divested by the 10% Owner at a price of $5.46 per share. As a result of the transaction, Coliseum Capital Management, L now holds 12,607,955 shares, worth roughly $29.25 million.
UBS downgraded its Accendra Health Inc [ACH] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who increased its forecast for the stock in mid July from “a Neutral” to “a Buy”. Leerink Partners began covering ACH with “Market perform” recommendation on February 26, 2024. Barclays started covering the stock on January 03, 2024. It rated ACH as “an Equal weight”.
Price Performance Review of ACH
On Friday, Accendra Health Inc [NYSE:ACH] saw its stock fall -17.14% to $2.32. Over the last five days, the stock has lost -14.39%. Accendra Health Inc shares have fallen nearly -81.67% since the year began. Nevertheless, the stocks have fallen -17.14% over the past one year. While a 52-week high of $15.54 was reached on 01/02/26, a 52-week low of $2.38 was recorded on 01/02/26.
Levels Of Support And Resistance For ACH Stock
The 24-hour chart illustrates a support level at 2.11, which if violated will result in even more drops to 1.91. On the upside, there is a resistance level at 2.71. A further resistance level may holdings at 3.11.
